Medicare’s GLP-1 Program Looms; Chemicals in Breast Milk; Acromegaly Drug Rejected
19/06/2026
Medicare’s GLP-1 Program A massive wave of new prescriptions for GLP-1 receptor agonists is expected following the July launch of
Medicare’s GLP-1 Program A massive wave of new prescriptions for GLP-1 receptor agonists is expected following the July launch of
CHICAGO — Few men prescribed testosterone therapy received guideline-concordant diagnostic testing for androgen deficiency, and some received therapy despite contraindications,
Legal and public health experts expressed concern about HHS Secretary Robert F. Kennedy Jr.’s scrutiny of a medical journal’s decision
The American Academy of Pediatrics (AAP) pushed backopens in a new tab or window on HHS Secretary Robert F. Kennedy
Clinical Takeaway: GLP-1 receptor agonists don’t appear to acutely suppress the male hypothalamic-pituitary-gonadal axis and may improve testosterone and some